The changing faces of migraine
Main Authors: | Paolo Martelletti, Messoud Ashina, Lars Edvinsson |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-05-01
|
Series: | The Journal of Headache and Pain |
Online Access: | http://link.springer.com/article/10.1186/s10194-019-1006-z |
Similar Items
-
Shaping the future of migraine targeting Calcitonin-Gene-Related-Peptide with the Disease-Modifying Migraine Drugs (DMMDs)
by: Paolo Martelletti, et al.
Published: (2019-05-01) -
Pituitary adenylate-cyclase-activating polypeptide (PACAP): another novel target for treatment of primary headaches?
by: Messoud Ashina, et al.
Published: (2018-05-01) -
Vasomotor reactions in the face and head of patients with migraine
by: Nita Wienholtz, et al.
Published: (2018-08-01) -
Guideline on the use of onabotulinumtoxinA in chronic migraine: a consensus statement from the European Headache Federation
by: Lars Bendtsen, et al.
Published: (2018-09-01) -
European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention
by: Simona Sacco, et al.
Published: (2019-01-01)